XML 49 R32.htm IDEA: XBRL DOCUMENT v3.22.0.1
Renasant Corporation (Parent Company Only) Condensed Financial Information
 12 Months Ended
Dec. 31, 2021
Condensed Financial Information Disclosure [Abstract]  
Renasant Corporation (Parent Company Only) Condensed Financial Information Renasant Corporation (Parent Company Only) Condensed Financial Information
(In Thousands)
Balance Sheets
  
December 31,
 20212020
Assets
Cash and cash equivalents(1)
$184,426 $129,164 
Investments2,009 7,174 
Investment in bank subsidiary(2)
2,477,917 2,306,937 
Accrued interest receivable on bank balances(2)
4 6 
Intercompany receivable(2)
— 184 
Other assets28,751 22,926 
Total assets$2,693,107 $2,466,391 
Liabilities and shareholders’ equity
Junior subordinated debentures$111,373 $110,794 
Subordinated notes359,419 212,009 
Other liabilities12,462 10,855 
Shareholders’ equity2,209,853 2,132,733 
Total liabilities and shareholders’ equity$2,693,107 $2,466,391 
(1)Eliminates in consolidation, with the exception of $1,857 and $844, in 2021 and 2020, respectively, pledged for collateral and held at non-subsidiary bank
(2)Eliminates in consolidation
Statements of Income
  
Year Ended December 31,
 202120202019
Income
Dividends from bank subsidiary(1)
$80,965 $81,443 $132,563 
Interest income from bank subsidiary(1)
7 9 9 
Other dividends80 93 175 
Other income32 74 138 
Total income81,084 81,619 132,885 
Expenses18,661 15,179 16,050 
Income before income tax benefit and equity in undistributed net income of bank subsidiary62,423 66,440 116,835 
Income tax benefit(4,795)(3,889)(4,077)
Equity in undistributed net income of bank subsidiary(1)
108,674 13,322 46,684 
Net income$175,892 $83,651 $167,596 
(1)Eliminates in consolidation
 
Statements of Cash Flows
  
Year Ended December 31,
 202120202019
Operating activities
Net income$175,892 $83,651 $167,596 
Adjustments to reconcile net income to net cash provided by operating activities:
Equity in undistributed net income of bank subsidiary(108,674)(13,322)(46,684)
Amortization/depreciation (accretion)891 692 (76)
Increase in other assets(5,628)(256)(2,678)
Increase in other liabilities6,952 10,932 10,872 
Net cash provided by operating activities69,433 81,697 129,030 
Investing activities
Purchases of securities available for sale— (6,104)— 
Sales and maturities of securities and available for sale5,100 541 42 
Other investing activities(100,000)— 632 
Net cash (used in) provided by investing activities(94,900)(5,563)674 
Financing activities
Cash paid for dividends(50,017)(50,134)(50,901)
Repurchase of shares in connection with stock repurchase program(21,315)(24,569)(62,944)
Repayment of long-term debt(45,000)— (30,973)
Proceeds from issuance of long-term debt197,061 98,266 — 
Net cash provided by (used in) financing activities80,729 23,563 (144,818)
Increase (decrease) in cash and cash equivalents55,262 99,697 (15,114)
Cash and cash equivalents at beginning of year129,164 29,467 44,581 
Cash and cash equivalents at end of year$184,426 $129,164 $29,467